HORSHAM, Pa. — Symphony Health Solutions on Tuesday named Frank Lavelle CEO.
“Frank Lavelle is a great leader who blends intense customer focus and strategic acumen," stated Romesh Wadhwani, chairman and CEO Symphony Technology Group. "In particular, his track record of leading organizations with strong customer intimacy as a key driver of success is a perfect match for us in his new role as CEO of Symphony Health Solutions,” she said. “Frank will be instrumental in leading Symphony Health Solutions to become the technology-driven market leader in differentiated data, research and analytics, with a laser focus on customer value creation. His relentless pursuit of excellence will drive our organization to achieve the highest quality execution and innovation to fuel growth.
“Quality management of the healthcare ecosystem to drive down expense while improving care is the only viable future for U.S. healthcare,” Lavelle said. “Healthcare data and insights are critical for not just for biopharma commercial organizations, but also communities, payers, providers and all manufacturers to understand and manage the business of health in a whole new way. The transformation of raw data to usable information to gain profound understanding is what we are all about. We will be relentlessly focused on delivering insights that enable our customers to make informed healthcare and business decisions in a daringly different way.”
For the past four years Lavelle served as the president and CEO of SunGard Data Systems’ K12 division, which provided technology solutions for the primary education marketplace. Lavelle has also served as the CEO for Siemens Medical Solutions and president for Medquist.
Launched in May 2012, Symphony Health Solutions was formed by the Symphony Technology Group by combining four complementary healthcare insight companies, including AlphaDetail, ImpactRx, Source Healthcare Analytics and TargetRx, into a single entity.
Find us on Facebook for more information on drug store news, insights and products.